Dubai’s Bioscience Institute is at the forefront of cutting-edge stem cell research, introducing advanced protocols to detect cancer drivers and analyze early aging processes.
By utilizing precise biopsy samples, the institute’s innovative techniques enable the identification of cells that may become cancerous in their initial stages.
Speaking at the ongoing Arab Health 2025 Exhibition and Conference at the Dubai World Trade Centre, Professor Giuseppe Mucci, Chief Executive Officer and Founder of the Bioscience Institute, emphasized the institution’s commitment to advancing early cancer detection and aging analysis. He highlighted that these breakthroughs not only enhance early treatment opportunities but also contribute significantly to public health improvement.
The institute is also pioneering biological solutions to assess the impact of aging, focusing on genomic toxicity and cellular changes. These technologies aim to identify factors contributing to premature aging, facilitating preventive measures to delay age-related diseases.
Professor Mucci further underscored the significance of stem cell therapy as a cornerstone of regenerative medicine. Unlike temporary cosmetic treatments, stem cell therapy promotes sustainable tissue regeneration and repair, enhancing overall health and slowing the aging process.
The Bioscience Institute’s ongoing research and innovative approaches position it as a key player in the global advancement of medical sciences, with the potential to revolutionize healthcare outcomes for patients in Dubai and beyond.
News Source: Emirates News Agency
